Molecular switch may sensitize triple-negative breast cancers to immunotherapy
Tuesday, August 30, 2016 - 04:51
in Health & Medicine
A new study offers compelling evidence that enzyme PRL-3 is 'switch' in TNF-R1 pathway, determining whether pathway helps cancer cells survive or die when challenged with immunotherapy.